We are early stage investors. We offer growth capital and strategic advisory.
Developing next generation genetic medicines with safe, effective, and redosable nucleic acid delivery technologies
Breakthrough Fusogenix gene delivery technology used to combat and treat COVID-19
Next generation cancer therapy targeting P53 delivered through a patented proteo-lipid vehicle
DNA-targeted intervention
to clear senescent cells
Intellectual property (IP) management software - Automated trademark docketing
RxTransparent acquired by
Inmar Intelligence, a
portfolio company of OMERS
Femtech. IoT enabled tracker measures changes in cervical fluid, aiding women's reproductive health
Personalized digestive health. Dieta solves IBS using data and AI
Revolutionary new test for Endometriosis
Remote biofeedback for telehealth providers and patients
Sea Monsters snacks (CPG)
Financial advisor
transition management
Copyright © 2025 Althea Group, LLC - All Rights Reserved.
Powered by